MedTrace Logo

Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin

NCT00597025 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 375

Last updated 2020-03-20

No results posted yet for this study

Summary

This study is to evaluate the impact of providing high protein supplementation in the form of a medical food bar containing 20grams of protein eath to hypoalbuminemic dialysis patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Protein Food Bar Intelligent Indulgence

Patients will be given one protein bar at each dialysis treatment, 3 times per week for 3 months

DIETARY_SUPPLEMENT

Protein Food Bar Intelligent Indulgence

Patients will be given 7 bars per week. In addition to the the three bars given on Hemodialysis each week, the patients will be given on the first treatment of the week four protein bars to be eaten on non-dialysis days

DIETARY_SUPPLEMENT

Protein Food Bar Intelligent Indulgence

Patients will be given a monthly supply of protein bars to provide for daily intake of one protein bar.

Sponsors & Collaborators

  • Satellite Healthcare

    lead OTHER

Principal Investigators

  • Brigitte Schiller-Moran, MD · Satellite Healthcare, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00597025 on ClinicalTrials.gov